GD
Gina D'Angelo
AstraZeneca, MedImmune LLC, University of Pittsburgh, Johns Hopkins University Bloomberg School of Public Health, Washington University in St. Louis
Employment
-
AstraZeneca Statistical Science Director2021 - Present
-
AstraZeneca Statistical Science Director2018 - 2021
-
MedImmune LLC Senior Principal Statistician2013 - 2018
-
Washington University in St. Louis Assistant Professor2007 - 2013
Education
-
University of Pittsburgh PhD1999 - 2005
-
Johns Hopkins University Bloomberg School of Public Health ScM1995 - 1998
Projects & Funding
Projects & funding information is unavailable.
Publications (8)
- Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now? Save
- CUI‐MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple‐Dose, Multiple‐Outcome Randomized Trials Save
- Predictive Biomarker Graphical Approach (PRIME) for Precision Medicine Save
- Utility‐Based Dose Optimization Approaches for Multiple‐Dose Randomized Trial Designs Accounting for Multiple Endpoints Save
- U-MET: Utility-Based Dose Optimization Approach for Multiple-Dose Randomized Trial Designs Save
- Tutorial on Firth's Logistic Regression Models for Biomarkers in Preclinical Space Save
- Pan-Cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer Therapeutics Save
- Statistical Models for the Analysis of Isobaric Tags Multiplexed Quantitative Proteomics Save